Pharma Journalist 9027 posts 0 comments

Merck, known as MSD outside the United States and Canada, announced that the company is discontinuing development of its SARS-CoV-2/COVID-19 vaccine candidates, V590 and V591, and plans…
Read More...

Humanetics Corporation (Humanetics) announced that it has received funding from the U.S. Department of Defense to conduct a series of studies with its new drug candidate, BIO 300. BIO…
Read More...

Evozyne, LLC, a privately held molecular engineering technology company founded by life science innovator Paragon Biosciences, announced the signing of a strategic collaboration and…
Read More...

Moderna Inc. announced results from in vitro neutralization studies of sera from individuals vaccinated with Moderna COVID-19 Vaccine showing activity against emerging strains of…
Read More...

BioNTech SE and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. announced that according to the Food and Health Bureau of the Hong Kong Special Administrative Region of the PRC ("Hong…
Read More...

SMi Reports: The only B2B parallel trade conference in Europe This conference will bring together industry experts to discuss the challenges and drivers of the industry, including…
Read More...

SMi Reports: The Virtual conference now only 2 weeks away The upcoming virtual conference now only 2 weeks away will bring together industry experts from leading RNA therapeutics…
Read More...

Eli Lilly and Company  announced the successful completion of its acquisition of Prevail Therapeutics Inc. The acquisition establishes a new modality for drug discovery and development…
Read More...

Elasmogen Ltd, the pioneering biopharmaceutical company leading the development of VNAR and soloMER™ biologics, announces a significant breakthrough in the identification of…
Read More...

SMi Group Reports: Six key microbiology presentations from FDA, STERIS, Boehringer Ingelheim Microbiological Consulting, Parexel will be discussed at SMi’s 4th Annual Pharmaceutical…
Read More...